Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus.
CONCLUSIONS: Adolescents with T1DM demonstrate IR and impaired vascular health compared with control participants. Metformin improves IR, regardless of baseline BMI, and BMI, weight, fat mass, insulin dose, and aortic and carotid health in adolescents with T1DM. Metformin may hold promise as a cardioprotective intervention in T1DM.
CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01808690.
PMID: 30566007 [PubMed - in process]
Source: Circulation - Category: Cardiology Authors: Bjornstad P, Schäfer M, Truong U, Cree-Green M, Pyle L, Baumgartner A, Garcia Reyes Y, Maniatis A, Nayak S, Wadwa RP, Browne LP, Reusch JEB, Nadeau KJ Tags: Circulation Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | DEXA Scan | Diabetes | Diabetes Mellitus | Diabetes Type 1 | Eating Disorders & Weight Management | Endocrinology | Fortamet | Heart | Insulin | Metformin | MRI Scan | Obesity | Ultrasound